Staoueli: A new plant for producing injectable medications under Hikma Pharma Algeria, a subsidiary of Jordan’s Hikma Pharma, has been inaugurated in Staoueli, west of Algiers. The facility, developed in collaboration with Hikma Pharma Portugal, will focus on manufacturing liquid ampoules and vials containing lyophilized powder for injectable preparations.
According to Algeria Press Service, the establishment of this plant marks a significant step in the local pharmaceutical industry. The plant aims to enhance the production capacity of injectable medications, which are crucial for various medical treatments. This initiative is expected to contribute to the local economy by creating jobs and reducing dependency on imported pharmaceutical products.
The collaboration between Hikma Pharma Algeria and Hikma Pharma Portugal emphasizes the strategic partnership aimed at leveraging expertise and resources to bolster the pharmaceutical sector in Algeria. The new facility in Staoueli is part of a broader effort to increase the availability of essential medications in the region.
Hikma Pharma’s investment in this plant aligns with its broader strategy to expand its manufacturing capabilities and presence in key markets. The company’s focus on producing high-quality injectable drugs is intended to meet the growing demand for these medications in Algeria and surrounding regions.